Nu Wave Investment Management, LLC Bluebird Bio, Inc. Transaction History

Nu Wave Investment Management, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$8.96 - $16.31 $116 - $212	-13 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$11.24 - $21.0 $146 - $273	13 New	13 $0
Q2 2021 Jul 16, 2021	SELL	$18.04 - $22.09 $64,727 - $79,258	-3,588 Closed	0 $0
Q1 2021 Apr 09, 2021	BUY	$16.59 - $33.89 $18,182 - $37,143	1,096 Added 43.98%	3,588 $108,000
Q4 2020 Jan 11, 2021	BUY	$27.5 - $37.92 $29,370 - $40,498	1,068 Added 75.0%	2,492 $108,000
Q3 2020 Oct 23, 2020	SELL	$34.44 - $43.75 $18,287 - $23,231	-531 Reduced 27.16%	1,424 $77,000
Q2 2020 Jul 13, 2020	BUY	$27.12 - $45.97 $11,309 - $19,169	417 Added 27.11%	1,955 $126,000
Q1 2020 Apr 14, 2020	BUY	$26.16 - $63.5 $25,584 - $62,103	978 Added 174.64%	1,538 $71,000
Q4 2019 Jan 31, 2020	SELL	$46.96 - $61.67 $10,706 - $14,060	-228 Reduced 28.93%	560 $49,000
Q3 2019 Oct 15, 2019	BUY	$59.47 - $93.1 $37,466 - $58,653	630 Added 398.73%	788 $71,000
Q2 2019 Jul 18, 2019	BUY	$75.84 - $105.21 $10,541 - $14,624	139 Added 731.58%	158 $20,000
Q1 2019 Apr 11, 2019	SELL	$64.44 - $104.11 $71,141 - $114,937	-1,104 Reduced 98.31%	19 $3,000
Q4 2018 Jan 22, 2019	BUY	$59.1 - $93.26 $8,333 - $13,149	141 Added 14.36%	1,123 $111,000
Q3 2018 Oct 23, 2018	BUY	$88.86 - $117.49 $86,460 - $114,317	973 Added 10811.11%	982 $143,000
Q2 2018 Aug 01, 2018	SELL	$99.64 - $127.59 $164,107 - $210,140	-1,647 Reduced 99.46%	9 $1,000
Q1 2018 May 02, 2018	BUY	$105.8 - $150.94 $94,479 - $134,789	893 Added 117.04%	1,656 $287,000
Q4 2017 Feb 07, 2018	BUY	$81.25 - $130.7 $61,993 - $99,724	763	763 $135,000

162

79.9M

525K

634K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $38.6M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nu Wave Investment Management, LLC with notifications on news.